Latest News View Older News
21 February 2023
White Paper | Identifying the Challenges in Rare Cancers Drug...
Drug development for rare cancers is challenging because it is difficult to obtain relevant data from very few patients. The oncology community is increasingly facing a disproportionate fraction of the total burden of cancers requiring multi-stakeholder cooperation and collaboration to complete rare cancer trials.
16 January 2023
Regulatory Dashboard | Decentralized Clinical Trials in the EU
Over the last decade, the development of digital health technologies has reshaped the way clinical trials are conducted. This has triggered a question on whether the traditional clinical trial, where patient treatment and data collection take place at the central location, is indeed the only way of ensuring patient safety and data integrity or if the same can still be achieved under a decentralized setting, with the use of digital tools and local health care providers.